GILD News 103.96 08/25/2014 05:09:21 Gilead Sciences (GILD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 103.96 $GILD

'Fast Money' Recap: Will Apple Shares Pull Back?
at The Street - Sat Aug 23, 4:00AM CDT
The trading panel discussed the company's all-time high and how to trade following Janet Yellen's Jackson Hole comments.

Most active Nasdaq-traded stocks
AP - Fri Aug 22, 5:03PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

Final Glance: Biotechnology companies
AP - Fri Aug 22, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 4:55PM CDT
Bristol-Myers (BMY) and partner Pfizer (PFE) announced that the FDA has cleared Eliquis for an additional indication.

Data on Celgene's Revlimid Published in Oncology Journal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 4:35PM CDT
Encouraging data was published on Celgen's (CELG) Revlimid in DLBCL.

3 Reasons Bristol-Myers Squibb's Stock Could Rise
George Budwell, The Motley Fool - Motley Fool - Fri Aug 22, 3:47PM CDT
The patent cliff has forced most Big Pharmas to make major transformations in their businesses over the past few years. Bristol-Myers Squibb  in particular has been ravaged by the loss of patent protection for blood thinner Plavix and a host of...

Amgen Upgraded to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 3:40PM CDT
On Aug 21, Zacks Investment Research upgraded Amgen Inc. (AMGN) to a Zacks Rank #1 (Strong Buy).

Gilead Sciences Set to Possibly Pullback After Yesterday's Rally of 1.65%
Comtex SmarTrend(R) - Fri Aug 22, 3:37PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $102.61 to a high of $105.16. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $102.57 on volume of 13.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of Gilead Sciences to Potentially Pullback after Yesterday's 1.65% Rise
Comtex SmarTrend(R) - Fri Aug 22, 3:36PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $102.61 to a high of $105.16. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $102.57 on volume of 13.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Midday Glance: Biotechnology companies
AP - Fri Aug 22, 12:22PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:

Next Resistance Level for Gilead Sciences (GILD) is $103.26
Comtex SmarTrend(R) - Fri Aug 22, 9:02AM CDT
Shares of Gilead Sciences (NASDAQ:GILD) have bullishly opened above the pivot of $101.81 today and have reached the first resistance level of $102.77. Investors may be interested in a cross of the next upside pivot targets of $103.26 and $104.71.

Repros Therapeutics (RPRX) Shows Strength: Stock Rises 5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 8:39AM CDT
Repros Therapeutics Inc. (RPRX) was a big mover last session, as its shares rose a little over 5% on the day.

Why Gilead Sciences (GILD) Could Beat Earnings Estimates Again - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 7:49AM CDT
Gilead Sciences has seen a nice streak of beating earnings estimates at the previous two reports, suggesting it has a nice short-term history of crushing expectations and that it could be a great candidate for another beat.

Jim Cramer's 'Mad Money' Recap: 12 Stocks Even Better Than Google
at The Street - Thu Aug 21, 6:59PM CDT
Google is fabulous, Cramer says, but these stocks are just as good if not better.

Bristol-Myers, Celgene Pair Up for Oncology Combo Treatments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 4:20PM CDT
Bristol-Myers (BMY) inked an oncology deal with Celgene (CELG).

Achillion Attains 52-Week High on ACH-3102 Patent Protection - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 4:00PM CDT
Achillion's (ACHN) shares touched a 52-week high of $10.18 on Aug 20 following its announcement that the USPTO has granted a patent to the company.

Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 3:55PM CDT
Amicus Therapeutics (FOLD) announced positive data from its second phase III study on migalastat.

Jim Cramer's Stop Trading: Don't Worry About Gilead Sciences
at The Street - Thu Aug 21, 10:10AM CDT
TheStreet's Jim Cramer says investors should not worry about Gilead Sciences, especially considering its low valuation.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Husqvarna's Q3 Numbers: A Mixed Bag of Woes and Wins

Updated Category News Views 3

Walking into Husqvarna’s latest interim report, it’s clear they’re facing an uphill struggle. Third quarter numbers can sting when they’re not in line with expectations, and Huskie's feeling the burn with a dip in net sales by 5% organically. Just look at that grimace on their bottom line—their operating income has hit SEK -334 million, a significant drop from...

Continue Reading
Purlin's Patent: Transforming Real Estate Deals

Updated Category News Views 6

Purlin's Game-Changer: A Patent in Real Estate Real estate has been chugging along like a stubborn mule, dragging deals through opaque negotiations and haphazard guessing games. Then enters Final Offer from Purlin Enterprises, waving a newly granted patent like a shiny golden ticket to those stuck trading homes in the dark. Leveling the Playing Field with Transparency In...

Continue Reading
VIVIFY and ELISIUM Plan Hydrogen-Powered City

Updated Category News Views 4

Hydrogen Takes Center Stage in Urban Planning Well, I didn't see this one coming—a city that's planning the power before the buildings. We're talking about ELISIUM, the so-called cognitive city destined to rise in Hendry County, Florida. And leading the charge in all this energy planning? None other than VIVIFY Technology, set to bring in its hydrogen expertise right...

Continue Reading
Hyliion Partnership Woes: Investors Eye Legal Options

Updated Category News Views 6

Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...

Continue Reading
NVIDIA GTC Unveils Fleet's New AI Device Support

Updated Category News Views 0

Expanding the AI Frontier: Fleet Meets NVIDIA NVIDIA just pulled a major move at their GTC Berlin event, rolling out a comprehensive suite of device management for their AI hardware ecosystem through Fleet. Picture this: IT folks can now handle NVIDIA’s flagship AI gear alongside all those pesky other devices without losing their minds or sleep. From RTX PRO...

Continue Reading
NEXT Properties' Exchange Offer Sees Strong Participation

Updated Category News Views 5

NEXT Properties Makes Bold Moves with Exchange Offers NEXT Properties has pulled the trigger on a massive swap of its notes, and it's a tale investors should tune into. They're swapping out their old notes like a veteran trader ditching penny stocks for blue chips. It’s an intriguing maneuver—risk-laden yet foreboding to anyone who knows the game. Breaking Down the...

Continue Reading
Teleste Unveils AI-Enhanced Rail Info Platform Innovation

Updated Category News Views 3

A Shake-Up in Rail Passenger Information Now, here's something from left field that might just have people paying attention while on the go. Teleste, a Finnish company, just put out a gem in rail passenger information systems with the introduction of Acapela's AI-based voice tech into their S-ARRIVE platform. Picture clearer, more natural announcements for every stop,...

Continue Reading
Shadeform's Spot: Monetizing Idle GPU Resources

Updated Category News Views 4

Shadeform's Spot Aims To Cut GPU Waste Imagine letting money burn while your GPUs sit in idle mode. That's the reality for many in the cloud computing sector, and Shadeform looks ready to tackle this inefficiency head-on. The launch of Spot, by the GPU Cloud Marketplace Shadeform, offers a novel way to make sure every floating gigaflop translates into some form of...

Continue Reading
Trimble's AI Boosts Construction Risk Management

Updated Category News Views 0

Navigating Construction's Risky Waters La-di-da, another day, another dollar lost—or won—in the construction zone. But hey, here comes Trimble waving a shiny new AI-driven flag that promises to shut down those wrench-tossing surprises in construction projects. They're calling it the Document Crunch, a tool that lets contractors review everything from drawings to...

Continue Reading
IBM Backs Leena AI: Shaping Enterprise Automation

Updated Category News Views 10

IBM's Strategic Bet on Enterprise Automation Diving into the blazing 2026 market, IBM Ventures has thrown its weight behind Leena AI, an enterprise agentic AI firm that's out to shake things up. You see, the name of the game isn't just flashy AI chatbots anymore. Companies like Leena AI are setting their sights on the back-office grunt work—the lifeblood operations in...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Drones as a Service for Defense and Military Applications

Updated Category News Views 122

Drones as a Service: Revolutionizing Military Operations Drones as a Service (DaaS) has emerged as a transformative solution for military and defense services, providing on-demand aerial data and imagery that is crucial for operational efficiency. Industries such as agriculture, construction, and energy have also embraced DaaS, but the military sector stands to gain the...

Continue Reading
Atmus Advances Filtration with Innovative NanoNet N3 Technology

Updated Category News Views 397

Atmus Unveils Innovative NanoNet N3 Filter Media Technology Atmus Filtration Technologies Inc. (NYSE: ATMU), a prominent leader in the field of filtration and media solutions, has recently introduced its latest technological advancement, known as NanoNet N3 filtration technology. This innovative media, crafted in-house, showcases a unique gradient mesh structure. It...

Continue Reading
Stripe's Impressive Growth Signals Major Shifts in Payments Industry

Updated Category News Views 451

Stripe's Remarkable Growth in the Payments Arena Stripe, a significant player in the fintech sector, has recently demonstrated exponential growth, processing around $1.4 trillion in payment volume last year, marking a dramatic 38% year-over-year increase. This impressive statistic has significant implications for established giants like PayPal, Adyen, and Fiserv....

Continue Reading
Oxbridge Re's Tokenized Reinsurance Sector Expansion in 2025

Updated Category News Views 256

Oxbridge Re: Pioneering Tokenized Reinsurance Oxbridge Re Holdings Limited (NASDAQ: OXBR), hailing from the Cayman Islands, is making waves in the world of reinsurance through innovative tokenization methods. This approach not only modernizes traditional reinsurance but also democratizes access to assets that were once limited to institutional investors. Their unique...

Continue Reading
Anterix Announces Important Q2 Earnings Call Details

Updated Category News Views 179

Anticipated Q2 Fiscal 2026 Earnings Call from Anterix On a noteworthy date, Anterix has set the stage for an engaging conference call that financial enthusiasts and stakeholders alike won’t want to miss. Announced from their headquarters in Woodland Park, Anterix, recognized in the market under the ticker NASDAQ: ATEX, will present their second quarter fiscal 2026...

Continue Reading